Purdue Pharma L.P., et al., Petitioners v. Accord Healthcare, Inc.

Track this case

Case Number:

24-1132

Court:

Supreme Court

Nature of Suit:

835 Patent - (ANDA) (Fed. Qst.)

Firms

Companies

Sectors & Industries:

  1. September 29, 2025

    Supreme Court Considers 7 Patent Petitions

    The U.S. Supreme Court held its first conference Monday, presenting the justices with several petitions of interest to patent practitioners before the court's new term kicks off next week.

  2. June 03, 2025

    Accord Urges Justices To Reject 'Crush-Resistant' Oxy IP Row

    Accord Healthcare Inc. says the U.S. Supreme Court should reject bankrupt OxyContin maker Purdue Pharma LP's attempt to revive its legal effort to use patent laws to block the release of a competing, "crush-resistant" generic painkiller.

  3. May 05, 2025

    Purdue Tells Justices 'Rigid' Fed. Circ. Rule Threatens Patents

    Bankrupt OxyContin-maker Purdue Pharma LP wants the U.S. Supreme Court to revive its legal effort to use patent laws to block the release of a competing "crush-resistant" generic painkiller, challenging a Federal Circuit decision that Purdue calls too "rigid."